Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications

Julia V Cockle1, Nadia Gopichandran, James J Walker

  • 1Perinatal Research Group, Leeds, United Kingdom.

Insights

Matrix metalloproteinases (MMPs) play a crucial role in preterm birth complications. Understanding MMPs and their inhibitors could lead to new therapies for preventing adverse perinatal outcomes.

Area of Science:

  • Biochemistry
  • Reproductive Biology
  • Neonatal Medicine

Background:

  • Preterm birth is a leading cause of neonatal mortality and morbidity.
  • Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and destruction.
  • Their dysregulation is implicated in various pregnancy and neonatal complications.

Purpose of the Study:

  • To review the role of MMPs in fetomaternal and neonatal complications associated with preterm birth.
  • To explore the regulation of MMPs by cytokines, hormones, and oxidative stress.
  • To identify MMPs as potential therapeutic targets for preterm birth complications.

Main Methods:

  • Literature review of studies on MMPs in preterm labor, preeclampsia, premature rupture of membranes, and neonatal outcomes.
  • Analysis of MMP involvement in tissue remodeling and destruction processes.
  • Examination of regulatory factors influencing MMP expression and activity.

Main Results:

  • MMP activation is linked to inflammatory responses in preterm labor, leading to membrane rupture and cervical changes.
  • Elevated MMP expression/activation occurs during premature parturition.
  • An imbalance between MMPs and their inhibitors contributes to neonatal complications like chronic lung disease and necrotizing enterocolitis.
  • MMPs are implicated in intraventricular hemorrhage, cystic periventricular leukomalacia, and retinopathy of prematurity.

Conclusions:

  • MMPs are significantly involved in the pathophysiology of preterm birth and its associated perinatal complications.
  • Therapeutic interventions targeting MMPs may offer a novel approach to managing these conditions.
  • Genetic polymorphisms in MMPs could serve as biomarkers for identifying at-risk individuals.